Correspondence mvidaki@mit.edu (M.V.), fgertler@mit.edu (F.B.G.) In Brief Vidaki et al. provide evidence that Mena, an actin regulator, forms a ribonucleoprotein complex in neurons, which involves translational repressors HnrnpK and PCBP1, and is required for local translation of dyrk1a and potentially other associated mRNAs in developing axons.
INTRODUCTION
During development, the exquisitely regulated process of axon guidance establishes the circuitry necessary for a properly functioning nervous system (NS) in the adult. Aberrant axonal navigation results in defective connectivity and multiple neurodevelopmental disorders, including-among others-epilepsy, intellectual disabilities, autism, and schizophrenia (McCandless, 2012; Sahin and Sur, 2015; Wegiel et al., 2010) . The growth cone, a specialized structure at the tip of growing axons, must continuously sample the microenvironment for guidance cues and integrate this information rapidly into appropriate motility responses, frequently without sufficient time for transcriptional responses. Indeed, axons severed from their cell bodies can navigate correctly in vivo and respond to guidance cues in vitro (Batista and Hengst, 2016; Campbell et al., 2001; Verma et al., 2005) .
Local mRNA translation is a key mechanism in such autonomous responses, and protein synthesis inhibitors block the ability of severed axons to respond to several guidance cues (Batista and Hengst, 2016; Jung et al., 2012) . However, most of our understanding of regulated local protein synthesis is based on the characterization of individual mRNAs found in axons (Deglincerti and Jaffrey, 2012; Kim and Jung, 2015) , with few details of the underlying molecular mechanism. Even in synapses, where local translation has been studied intensely, only a few proteins have been identified as key regulators of local mRNA translation (Bassell and Warren, 2008; Brown et al., 2001; Darnell et al., 2011; De Rubeis and Bagni, 2010; Deglincerti and Jaffrey, 2012; Fritzsche et al., 2013; Hutten et al., 2014; Kindler et al., 2012) .
Mena (ENAH), a member of the Ena/VASP protein family, is highly expressed in the developing and adult NS and is a known regulator of actin dynamics, integrin-mediated signaling, adhesion, and cell motility (Bear and Gertler, 2009; Drees and Gertler, 2008; Gupton and Gertler, 2010; Gupton et al., 2012) . Mena and its paralogs, VASP and EVL, are required for normal NS development during neurulation (Lanier et al., 1999; Menzies et al., 2004) , neuritogenesis, migration Kwiatkowski et al., 2007) , axon guidance responses to both attractive and repulsive signals (Lebrand et al., 2004; Dent et al., 2011; McConnell et al., 2016) , terminal axon branching (Dwivedy et al., 2007) , dendritic morphology, and synapse formation (Li et al., 2005; Lin et al., 2007) . Of the three Ena/VASP proteins, Mena is the most abundant in the NS, and Mena null animals exhibit clear defects in NS development, while VASP/ EVL double mutants exhibit no obvious NS phenotypes in animals with a wild-type (WT) Mena allele . Further, while Ena/VASP family proteins share a highly conserved domain structure, Mena contains additional domains and alternatively included sequences not found in VASP or EVL (Gertler and Condeelis, 2011) .
Here, we identify a ribonucleoprotein (RNP) complex containing Mena, known translation regulators, and specific cytosolic mRNAs, including dyrk1a. Dyrk1a, a dual specificity kinase with multiple roles in neuronal development, has been implicated in the pathology and etiology of Down syndrome (DS), autism, intellectual disabilities, Alzheimer's disease, and Parkinson's disease (Coutadeur et al., 2015; Di Vona et al., 2015; Krumm et al., 2014; O'Roak et al., 2012; Qian et al., 2013; Tejedor and H€ ammerle, 2011; van Bon et al., 2016) . We demonstrate a critical (B) Proteins enriched in Oligo(dT) pull-downs, analyzed by western blot probed with antibodies to Mena and to positive control RBPs, FMR1, and MBNL1, as indicated (input is 5% of total lysate). (C) Schematic representation of the modified HITS-CLIP protocol. E15.5 mouse brain tissues were triturated and UV crosslinked to preserve RNP complexes and then homogenized in mild lysis buffer to generate lysates for Mena IP. CoIPed RNA was subsequently isolated and sequenced.
(legend continued on next page) role for Mena in Dyrk1a protein synthesis both under steadystate conditions and after BDNF stimulation.
RESULTS

Novel Interactions of Mena with Multiple RNA-Binding Proteins in the Developing Brain
To explore the mechanisms underlying Mena function beyond its established roles in actin polymerization (Bear and Gertler, 2009) and in integrin-mediated signaling Gupton et al., 2012; Gupton and Gertler, 2010) in the developing NS, we sought to identify its interactome. We performed mass spectrometry after immunoprecipitation (IP) of Mena from lysates of embryonic day 15.5 (E15.5) mouse brains from Mena wild-type and Mena-deficient animals. Along with known Mena-binding partners, including PFN2 and EVL (Giesemann et al., 2003; Riquelme et al., 2015) , we identified additional Mena-associated proteins (Table S1) . Surprisingly, multiple RNA-binding proteins (RBPs), including translation factors and mRNA transport proteins, were identified in the Mena IP ( Figure S1A ). To verify the specificity of these interactions, we performed coIP experiments from E15.5 mouse brains and found that several of these RBPs coIPed specifically with Mena, while FMR1, an RBP not identified by our proteomic screen, did not ( Figure 1A ; multiple bands appearing on the Mena western blot [WB] correspond to different Mena protein isoforms; Gertler et al., 1996; Lanier et al., 1999) . Several of the Mena-RBP interactions were also detected in N2A neuroblastoma cells and in mouse embryonic fibroblasts (MEFs) (Figures S1B and S1C). Interestingly, RNase treatment of brain lysates did not affect the recovery of RBPs in Mena coIPs (data not shown), indicating that these Mena-RBP interactions do not depend on the presence of RNA.
Mena Associates with Cytosolic mRNAs In Vivo
Given that Mena associated with multiple RBPs in developing brain lysates, we wondered whether Mena-containing complexes were also associated with mRNA. To test this hypothesis, we used Oligo(dT) pull-down assays to capture polyadenylated mRNAs and mRNA-associated proteins from lysates prepared from brain tissue that was UV crosslinked to preserve RNAprotein complexes ( Figure S1D ; Figure 1B ). WB analysis of the captured proteins indicated that Mena was associated with mRNA ( Figure 1B ). To test whether this association is neuronal specific, we performed additional Oligo(dT) pull-down assays and found that, in MEFs, Mena is also in complex with cytosolic mRNAs ( Figure S1E ).
Identification of mRNAs Associated with Mena in the Brain
Mena can bind directly to a number of proteins, including ligands for its EVH1 (Ena/VASP Homology-1) domain, actin through its EVH2 domain, and a5 integrin through its LERER domain, but lacks any known RNA-binding sites (Bear and Gertler, 2009; Gertler et al., 1996; Gupton et al., 2012) , raising the possibility that it associates with mRNA indirectly via one or more RBPs. To investigate this possibility, and to identify mRNAs in complex with Mena in neurons, we performed IP after crosslinking (CLIP) assays. UV crosslinking was used to preserve RNA-protein complexes in E15.5 mouse brain tissues, followed by lysate preparation and Mena IP. The stringent lysis conditions typically used for CLIP diminished recovery of RNA associated with Mena by coIP (data not shown), suggesting that the association of Mena with mRNA may be indirect. A modified CLIP protocol with mild lysis and IP conditions improved mRNA recovery in the Mena IP, allowing us to sequence the associated mRNA ( Figure 1C : modified high-throughput RNA sequencing after CLIP [HITS-CLIP]; see Star Methods) (Darnell, 2010; Licatalosi et al., 2008) . Binding peaks were identified by the presence of multiple sequence reads in the sample that exhibited more than ten reads and that were at least 3-fold enriched in the Mena versus control CLIP samples (Table S2 ). The majority of the peaks were distributed within exons (48%) or gene regions (47.8%), while 4.2% of peaks mapped to the 5 0 or 3 0 UTRs of mRNAs ( Figure S1F ; Table S2 ).
To identify potential biological processes controlled by the Mena-associated mRNAs, gene set enrichment analysis was performed using the Broad Institute platform (http://software. broadinstitute.org/gsea/index.jsp) ( Figure 1D ; Table S2 ). Several of the most enriched gene sets represented processes that involve Mena function (e.g., axon guidance, Robo signaling, etc.) ( Figure 1D ). To confirm the specific association of selected mRNAs within each category with Mena, we performed quantitative RT-PCR after Mena CLIP assays from control and Mena null E15.5 brains (referred to as mve throughout the text) ( Figure 1E ). Interestingly, some of the Mena complex-associated mRNAs encode proteins that have been functionally linked to Mena (e.g., Vamp2, Gupton and Gertler, 2010; Robo1, Bashaw et al., 2000; McConnell et al., 2016; Yu et al., 2002; Ctnnb1, Najafov et al., 2012) , while others represent processes not previously associated with Mena (e.g., Khsrp, Elavl1, Eif4ebp2, Dyrk1a, etc.) . Two of the most prevalent mRNAs identified by sequencing were those of dyrk1a and mena itself, both demonstrating multiple sequencing peaks in their gene region and in their 3 0 UTR ( Figure 1F ). Together, these data indicate that Mena can indirectly associate with specific mRNAs via its interacting RBPs in a novel RNP complex in the developing NS.
Mena Associates with the mRNA of dyrk1a in Neurons
The dyrk1a mRNA encodes a dual specificity kinase that has multiple functions in the NS (Barallobre et al., 2014; H€ ammerle et al., 2003 Tejedor and H€ ammerle, 2011) . Dyrk1a inhibitors are being tested in Alzheimer's disease treatment (Coutadeur et al., 2015; Janel et al., 2014) , whereas in models of (D) Gene set enrichment analysis (REACTOME) of the mRNAs identified through Mena HITS-CLIP. (E) qPCR validation of several mRNAs that specifically associated with Mena. Mena null brains were used as experimental controls. The graph represents relative mRNA enrichment of Mena-associated mRNAs between the WT and mve samples ± SD (Student's t test, *p < 0.05).
(F) Peaks in the 3 0 UTRs of mena and dyrk1a. Parkinson's disease Dyrk1a acts as a dopaminergic neuron survival factor (Barallobre et al., 2014) . Moreover, Dyrk1a has been implicated in cases of autism and intellectual disability (Krumm et al., 2014; O'Roak et al., 2012; van Bon et al., 2016) , and a Dyrk1a dosage-dependent role has been correlated with DS etiology and pathology (H€ ammerle et al., 2003 Tejedor and H€ ammerle, 2011) . Our HITS-CLIP data indicated that the Mena complex associated with the 3 0 UTR of dyrk1a mRNA ( Figure 1F ). As RBP binding to 3 0 UTRs can regulate cytosolic mRNA localization and translation (Szostak and Gebauer, 2013) , we hypothesized that Mena might be important for dyrk1a mRNA dynamics in neurons.
To detect dyrk1a mRNA and determine whether it co-localizes with the Mena protein, we performed immunofluorescence (IF) for Mena along with fluorescent in situ hybridization (FISH) for dyrk1a mRNA on cultured cortical neurons ( Figure 2A dyrk1a mRNA Can Be Co-recruited to the Mitochondrial Surface along with Mena in a Re-localization Assay To test whether Mena can affect the cytoplasmic localization of dyrk1a mRNA, we used a well-established mitochondrial sequestration assay (Bear et al., 2000) in which the expression of a construct with the high-affinity EVH1 domain-binding motif DFPPPPXDE fused to a mitochondrial targeting sequence (''FP4-mito'') re-localizes endogenous Ena/VASP proteins to the mitochondrial surface ( Figure S2B ). Expression of a control construct in which the EVH1-binding moiety is mutated to reduce affinity for EVH1 domains (''AP4-mito'') has only minimal effects on Ena/VASP re-localization. Using this assay, the vast majority of Mena (and its paralogs) is re-localized to the mitochondria, and in some cases, robustly interacting proteins are co-recruited (Gupton et al., 2012) . We thus reasoned that any mRNA associated with a Mena-containing RNP complex might also be co-recruited with Mena to the mitochondria by FP4-mito. Using nucleofection, we expressed the FP4-and AP4-mito constructs in primary neurons from E15.5 mouse brains. 48 hr after nucleofection and plating, we performed FISH to detect the mRNA of dyrk1a in FP4-and AP4-mito-expressing neurons. Expression of the constructs did not affect the total levels of dyrk1a mRNA ( Figure S2C ). Interestingly, we found that a significant amount of dyrk1a mRNA was co-recruited with Mena to the mitochondrial surface by FP4-mito ( Figures  2D, a-d , and 2E, i), whereas dyrk1a mRNA localization was unaffected in AP4-expressing control neurons ( Figures 2D, a 0 -d 0 , and 2E, ii). The correlation between Mena and dyrk1a mRNA was significantly elevated on the mitochondrial surface of FP4-versus AP4-mito-transfected neurons ( Figure 2F ). In contrast to the mRNA, IF analysis indicated that localization of the Dyrk1a protein was unaffected by FP4-mito expression ( Figure S2D ).
Taken together, our data demonstrate that Mena and dyrk1a mRNA interact specifically and co-localize within neuronal axons and growth cones and that this interaction is sufficient to relocalize the dyrk1a mRNA to mitochondria in an Ena/VASPdependent manner.
Mena Is Necessary and Sufficient to Re-localize dyrk1a mRNA to the Mitochondria To test whether other members of the Ena/VASP family can also be found in complex with mRNAs, we performed VASP CLIP assays. Using RT-PCR, we failed to detect Mena-associated mRNAs in complex with VASP ( Figure S2E ). We also failed to detect VASP associated with cytosolic mRNAs after Oligo(dT) pull-down assays (data not shown), suggesting that the ability to associate with RNP complexes may be Mena specific rather than a general property of Ena/VASP proteins. To test this hypothesis, we introduced FP4-mito into neurons isolated from Mena E15.5 brains and analyzed the resulting effects on dyrk1a mRNA distribution. In the absence of Mena, both VASP (Figure S2F) and EVL (data not shown) were recruited to the mitochondria by FP4-mito, as expected, but the mRNA of dyrk1a was not ( Figure S2G ). Therefore, Mena, unlike the other members of the Ena/VASP family, is necessary and sufficient to re-localize dyrk1a mRNA to the mitochondria upon FP4-mito expression. As these data indicate that the ability to associate with dyrk1a and other mRNAs was Mena specific, we focused exclusively on characterizing the Mena-mRNA association in this study.
Candidate RBPs Mediating the Interaction between Mena and mRNAs
To understand the biological significance of the association between Mena and specific mRNAs, we investigated how RBPs mediate this indirect interaction. We used a custom script to perform an unbiased analysis to identify sequences enriched within the 3 0 UTRs of the Mena-associated mRNAs that could serve as potential RBP motifs. For simplicity, we searched only for hexamer sequences, as they have been previously identified as highly efficient kmer motifs with minimal contextual binding effects (i.e., secondary structure formation, etc.) (Lambert et al., 2014) . Interestingly, most of the enriched hexamers identified corresponded to binding motifs of RBPs that interact with Mena according to both our mass spectrometry data and coIP validation experiments ( Figure 3A ). More specifically, the 3 0 UTR sequences derived from our Mena-HITS-CLIP data were enriched significantly for binding motifs of HnrnpK, PCBP1 (HnrnpE1), and Safb2, all of which were verified as interactors of Mena in brain lysates ( Figure 1A ; Figure S1A ). To test whether HnrnpK, Safb2, and PCBP1 could potentially mediate the indirect association of Mena with cytosolic mRNAs, we investigated whether they bind to the 3 0 UTR of the dyrk1a mRNA. We analyzed the sequences corresponding to the 3 0 UTR of dyrk1a in our Mena-HITS-CLIP data using the RBPmap platform (http://rbpmap.technion.ac.il) (Akerman et al., 2009; Paz et al., 2010) and identified putative binding sites for HnrnpK, PCBP1, and Safb2, among others ( Figure S3A ; Table S3 ). To confirm that PCBP1, HnrnpK, Safb2, and Mena could associate with the 3 0 UTR of dyrk1a mRNA, we performed mRNA pull-down assays using an in vitro transcribed biotinylated probe corresponding to the 3 0 UTR of dyrk1a mRNA to capture interacting protein complexes from E15.5 brain lysates ( Figure 3B ). WB analysis of the captured fraction revealed that all three candidate RBPs, as well as Mena, were enriched in the bound fraction associated with the 3 0 UTR of dyrk1a, but not with a control biotinylated RNA probe, consistent with our previous in silico predictions ( Figure 3C ). Further analysis using simultaneous dyrk1a FISH and IF for Mena and HnrnpK revealed co-localization of the three fluorescent signals in the growth cones of primary neurons ( Figure S3B ), consistent with the existence of a Mena-RNP complex.
Taken together, our data indicated that the Mena-interacting RBPs HnrnpK, PCBP1, and Safb2 could mediate indirect association of Mena with dyrk1a, since all three can bind to the dyrk1a 3 0 UTR. We then asked whether any of the candidate RBPs were required for the association of Mena with dyrk1a mRNA in neurons.
To address this question, we sought to analyze the effects of depleting the RBPs on the extent of overlap between the Mena IF and dyrk1a FISH signals. We introduced small interfering RNA (siRNA) pools for each RBP into primary neurons by co-nucleofection with a GFP plasmid to identify transfected neurons. As the nucleofection efficiency of siRNAs into primary neurons is low, and the resulting protein depletion is limited by the non-proliferative phenotype of primary neurons, we assessed the efficacy of depletion by each siRNA pool using IF for the proteins. Using this approach, we were able to generate convincing knockdown of HnrnpK, but not of either PCBP1 or Safb2 ( Figure S3C ; data not shown). We then asked whether co-localization between Mena and dyrk1a was sensitive to reduction in HnrnpK levels. We found that although HnrnpK depletion did not affect the protein and mRNA levels of Mena and dyrk1a, respectively, neither in total cells nor in the growth cone area and its proximal axon ( Figure S3D ), it significantly reduced the signal overlap (Figures 3D, large white arrows, and 3E), with more dyrk1a puncta lacking co-localized Mena signal ( Figure 3D , small white arrows). This result is consistent with our hypothesis that HnrnpK is involved in mediating the interaction between Mena protein and dyrk1a mRNA. dyrk1a mRNA Is Locally Translated in Axons upon Stimulation with BDNF Based on the known roles of HnrnpK and PCBP1 in regulating cyotosolic mRNA localization and translation (Thiele et al., 2004; Torvund-Jensen et al., 2014) , we hypothesized that Mena-RNP complexes could facilitate transportation and/or local translation of the associated mRNAs in axons and growth cones. To test this hypothesis, we stimulated neurons in culture with brain-derived neurotrophic factor (BDNF) to elicit local translation (Jung et al., 2012; Santos et al., 2010; Schratt et al., 2004) and analyzed Dyrk1a protein abundance. We also tested the protein levels of Mena, as our sequencing data indicated that the mena mRNA associated with the protein. IF of primary cortical neurons showed that both Mena and Dyrk1a fluorescence intensity levels significantly increased in the growth cones and axons of BDNFstimulated versus unstimulated cells ( Figure S4A ). This effect was blocked by addition of the translation inhibitor anisomycin, indicating that the increase in the Dyrk1a and Mena IF signal resulted from BDNF-elicited protein synthesis ( Figure S4A ).
The BDNF-induced increase in axonal Mena and Dyrk1a proteins could arise from a global effect on their synthesis followed by protein trafficking into axons and growth cones or, potentially, from local translation of axon-localized mRNAs. To investigate this possibility, we cultured cortical neurons on the top compartment of transwell chambers separated by filters with 1 mm membrane pores ( Figure 4A ) that allow neuronal processes, but not neuronal cell bodies, to extend onto the bottom of the filter and permit their physical fractionation from the soma. 36-48 hr after plating primary neurons on top of the filter, material harvested from the top and bottom compartments of the chamber was isolated and used to prepare lysates. WB analysis of lysates from the top and bottom compartment with known axon (panTau), dendrite (Map2), and nuclear (Tbr1) markers, 36-48 hr after plating, verified that this assay successfully separates somata from neuronal processes ( Figure 4B , absence of Tbr1 at the bottom compartment) and that the neuronal processes isolated from the bottom were primarily axons as opposed to dendrites ( Figure 4B , enrichment of Tau and barely detectable levels ofBDNF Stimulation Decreases the Association between Mena and dyrk1a mRNA Given that BDNF can induce translation of dyrk1a mRNA in developing neurons, we investigated whether and how the stimulation affects the association of Mena with dyrk1a. First, we asked whether the extent of Mena protein co-localization with dyrk1a mRNA in growth cones was altered upon stimulation. We performed IF for Mena and FISH for dyrk1a in cortical neurons with and without BDNF stimulation ( Figure 5A ). Notably, we observed an increase in the FISH signal of dyrk1a mRNA after BDNF stimulation both in the growth cones and their proximal axon part (Figure 5B) , indicating that increases in dyrk1a transcription, mRNA transport, or both occur upon BDNF stimulation. Interestingly, the overlap between the Mena IF and dyrk1a FISH signals was significantly decreased by BDNF treatment, raising the possibility that Mena:dyrk1a-containing complexes dissociate upon stimulation ( Figure 5C ). To test this hypothesis, we used the mitochondria re-localization assay described above and found that the amount of dyrk1a co-recruited with Mena to mitochondria in FP4-mito-expressing neurons was reduced significantly by BDNF treatment ( Figure 5D ) compared to unstimulated neurons ( Figure 5E ).
Overall, our results demonstrate that while BDNF stimulation increases total dyrk1a mRNA levels and local translation in axons, it reduces the association of Mena and dyrk1a.
BDNF Stimulation Results in Partial Dissociation of the Mena;dyrk1a RNP Complexes
We next investigated the effects of BDNF stimulation on Mena:RNP complexes. We found that the levels of HnrnpK and PCBP1 recovered with Mena by coIP were significantly reduced in lysates of BDNF versus unstimulated cultured primary neurons ( Figures 6A and 6B ). Taken together, these results suggest that BDNF stimulation induces Mena-RBP complex dissociation, which could lead to the dissociation of dyrk1a mRNA from Mena. To test this hypothesis, we performed pull-downs using biotinylated dyrk1a 3 0 UTR from the lysates of neurons with or without BDNF stimulation. An irrelevant 3 0 UTR from lhx6, an mRNA not detected in the Mena-HITS-CLIP data (Table S2) , was used as a negative control for the binding assay. Consistent with our previous findings, we observed that BDNF induced a significant increase in the protein levels of Mena and HnrnpK (Figures 6C, input, and 6D; Figure S4B) ; however, the amounts of Mena, HnrnpK, and PCBP1 pulled down with the 3 0 UTR of dyrk1a mRNA were significantly decreased by BDNF stimulation ( Figures  6C, pull-down fraction, and 6D) . Therefore, the exogenous 3 0 UTR dyrk1a probe associated with the Mena-RBP complex more efficiently in the unstimulated condition than it did after stimulation. Together, these data indicate that, in addition to eliciting translation of dyrk1a, BDNF stimulation triggers dissociation of Mena from its interacting RBPs and from the dyrk1a mRNA. (E) BDNF stimulation of axons only elicits a greater increase in the protein levels of both Mena and Dyrk1a in axonal lysates.
(F) Quantification of the proteins in isolated axonal preparations reveals significant changes upon BDNF stimulation. All values were normalized to loading controls (GAPDH) and then to the unstimulated protein levels to generate fold changes. The graph represents mean ± SD (two-way ANOVA, *p < 0.05).
Based on our results, we hypothesized that HnrnpK, which contributes to the association between Mena and dyrk1a, would be required to detect the BDNF-elicited reduction in their colocalization. We performed FISH for dyrk1a and IF for Mena in HnrnpK-depleted neurons ( Figure 6E ) and found that, as expected, the overlap between the fluorescence was significantly reduced compared to controls in the absence of HnrnpK in unstimulated cells (Figures 3D and 6F) . Interestingly, HnrnpKdepleted neurons failed to exhibit any further significant reduction of Mena and dyrk1a co-localization after BDNF stimulation ( Figure 6F ).
Taken together, this set of results indicates that the association of dyrk1a mRNA with Mena depends, at least in part, on the presence of HnrnpK in unstimulated cells, suggesting that BDNF-elicited decreases in MenaHnrnpK association could contribute to Mena dissociation from dyrk1a-containing RNPs.
The Absence of Mena Disrupts Dyrk1a Translation but Does Not Affect Axonal Targeting of the dyrk1a mRNA Thus far, our data reveal an association between Mena and dyrk1a through the formation of Mena-RNP complexes and a potential role for those complexes in dyrk1a mRNA translation. We next investigated the requirement for Mena in dyrk1a localization and translation using material from Mena-deficient animals. WB analysis of E15.5 whole-brain lysates revealed a significant decrease in Dyrk1a protein levels in Mena-deficient brains compared to control (Figures 7A and 7B) .
To test whether local translation of the dyrk1a mRNA requires Mena-containing complexes, we examined the effect of BDNF stimulation on axons isolated from WT and mve primary cortical neurons. We observed that, compared to control, mve axons had significantly lower Dyrk1a protein levels under steady-state conditions and that Dyrk1a levels failed to increase upon BDNF stimulation ( Figures 7C and 7D) .
To verify that the Dyrk1a protein level reduction observed in mve neurons arose from defective translation rather than abnormal mRNA transport, we performed FISH for dyrk1a on mve neurons. While dyrk1a mRNA was normally targeted to axons and growth cones in both samples, dyrk1a mRNA levels were significantly increased in mve neurons compared to control cells (Figures 7E and 7F ). This could be explained by compensatory transport from the soma and/or mRNA unmasking in the absence of Mena. Signal increases arising from mRNA unmasking can occur upon neuronal activation as mRNAs are released from protein complexes during translation or decay (Buxbaum et al., 2014) . Pepsin treatment on WT neurons in culture as previously described (Buxbaum et al., 2014) , followed by FISH, revealed a significant increase in the dyrk1a signal between untreated and pepsin-treated cells ( Figure S5 ), indicating that part of dyrk1a RNA is masked by proteins in the absence of stimulation. To analyze the abundance of dyrk1a mRNA in mve neurons in a protein complex-independent manner, we isolated total RNA and performed quantitative RT-PCR analysis for dyrk1a and observed significantly higher dyrk1a mRNA levels in mve versus control neurons ( Figure 7G ). The increased abundance of dyrk1a mRNA in the absence of Mena likely arises as a consequence of elevated dyrk1a transcription, increased mRNA stability, or both, potentially triggered by impaired translation of dyrk1a mRNA.
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DISCUSSION
We found an unanticipated role for Mena, but not for its paralogs VASP and EVL, as a key regulator of dyrk1a mRNA translation in neurons and have identified a set of Mena-associated mRNAs that may be similarly regulated. Using BDNF to elicit protein synthesis (Santos et al., 2010; Schratt et al., 2004) , we demonstrated that the mRNAs encoding Mena and Dyrk1a can be locally translated in axons severed from their cell bodies and that this de novo protein synthesis is Mena dependent. Our findings raise the intriguing possibility that Mena could act as a regulatory node that coordinates and balances actin polymerization and local protein synthesis in response to specific cues during neuronal development and, potentially, in adult neuroplasticity.
Interestingly, similar dual roles have been reported for CYFIPs, which can function either as a regulator of Arp2/3-mediated actin nucleation through the WAVE-complex or as a local translation inhibitor in synaptic spines via direct binding to the FMR1 RBP (De Rubeis et al., 2013) , and for APC, which regulates microtubule dynamics, mRNA enrichment in filopodia (Mili et al., 2008) , and axonal localization and translation of b2B-tubulin mRNA (Preitner et al., 2014) . Notably, the mRNA set we have identified as associated with Mena is significantly different from mRNAs already known to be locally translated and associated with well-described RBPs, including FMR1, APC, Staufen, and Barentsz (Ascano et al., 2012; Balasanyan and Arnold, 2014; Brown et al., 2001; Fritzsche et al., 2013; Preitner et al., 2014) , minus few exceptions (e.g., b-catenin; Baleriola and Hengst, 2015; Deglincerti and Jaffrey, 2012) , suggesting that the Mena-containing complexes represent a novel RNP complex involved in localized mRNA translation in axons. Mena associates indirectly with dyrk1a and other cytosolic mRNAs in an RNP containing the RBPs HnrnpK, PCBP1, and Safb2. Binding motifs for these three RBPs were enriched significantly in Mena complex mRNAs, and they were all detected in pull-down assays with the dyrk1a 3 0 UTR. HnrnpK plays a critical role in linking Mena to mRNAs as HnrnpK depletion significantly reduced association between Mena and dyrk1a mRNA. Exactly how the Mena-RNP complex forms and connects Mena to specific mRNAs will require further investigation, though it is noteworthy that HnrnpK and Safb2 both contain LP4 motifs, which can mediate direct binding to the EVH1 domain of Ena/ VASP proteins (Niebuhr et al., 1997) , and that Safb2 (Townson et al., 2003) also contains a region of similarity to the LERER domain in Mena.
Two of the RBPs we found to be associated with Mena, HnrnpK, and PCBP1 have varied roles in RNA metabolism, including regulation of mRNA translation (Gebauer and Hentze, 2004; Ostareck-Lederer et al., 2002; Thiele et al., 2004; Torvund-Jensen et al., 2014) . Interestingly, HnrnpK and PCBP1 can form complexes that inhibit translation initiation when bound to the 3 0 UTRs of target mRNAs (Gebauer and Hentze, 2004) . But how can Mena be associated with an mRNA and positively regulate its translation when present in a complex that silences dyrk1a translation? Our results are consistent with the possibility that dyrk1a is translationally silenced by the HnrnpK and PCBP1 moieties in the Mena-RNP complex and that de-repression of dyrk1a translation requires Mena. In Mena-deficient neurons, steady-state levels of Dyrk1a protein are reduced, and BDNF stimulation fails to induce dyrk1a translation. Our data showing that BDNF stimulation disrupts Mena's association with HnrnpK and PCBP1, as well as the recovery of Mena, HnrnpK, and PCBP1 in pull-downs using the 3 0 UTR of dyrk1a, supports a speculative model in which dissociation of the Mena-RNP complex releases dyrk1a mRNA from its translationally inhibited state.
The Mena-RNP complex is significantly enriched for many mRNAs encoding proteins involved in NS development and function, including dyrk1a. Dyrk1a is a dosage-sensitive, dualspecificity protein kinase that fulfills key roles during development and in tissue homeostasis, and its dysregulation results in multiple human pathologies (Chen et al., 2013; H€ ammerle et al., 2003; O'Roak et al., 2012; Qian et al., 2013; Tejedor and H€ ammerle, 2011) . Human Dyrk1a maps to chromosome 21, and it is overexpressed in DS individuals and DS mouse models. This alteration has been correlated with a wide range of the pathological phenotypes associated to DS, such as motor alterations, retinal abnormalities, osteoporotic bone phenotype, craniofacial dysmorphology, or increased risk of childhood leukemia (Arron et al., 2006; Kim et al., 2016; Malinge et al., 2012; Ortiz-Abalia et al., 2008; van Bon et al., 2016) . In addition, a few cases of truncating mutations in one dyrk1a allele have been described in patients with general growth retardation and severe primary microcephaly (van Bon et al., 2011) , highlighting the extreme dosage sensitivity of this gene. Moreover, and as an indication of the pleiotropic activities of Dyrk1a, dysregulation of this kinase has also been linked to tumor growth and to pancreatic dysfunction (Ferná ndez-Martínez et al., 2015; Rachdi et al., 2014) .
Like most of the mRNAs identified in this study, dyrk1a contains multiple binding sites for the Mena complex in its 3 0 UTR, consistent with our data demonstrating that the Mena-RNP complex regulates local synthesis of Dyrk1a protein. Given the extreme dosage sensitivity of Dyrk1a and its implication in numerous neurodevelopmental disorders, our finding that Dyrk1a protein levels are regulated in a Mena-dependent manner in axons raises the intriguing possibility that dysregulation of the Mena-RNP complex may contribute to such disorders. Additional mRNAs that are associated with Mena, like the validated targets b-catenin and elavl1 (HuR) are also implicated in multiple developmental processes and pathophysiological conditions (Alami et al., 2014; Blanco et al., 2016; Holland et al., 2013; Krumm et al., 2014; Li et al., 2017; Lu et al., 2014; O'Roak et al., 2012; Wang et al., 2016) . Therefore, the Mena-RNP complex may represent a target for the development of novel therapeutic strategies for multiple disease pathologies.
Interestingly, the Mena-RNP complex contains mena mRNA, which harbors multiple binding sites for the complex in its 3 0 UTR, raising the possibility that Mena regulates translation of its own mRNA. Mena-regulated translation of b-catenin could also affect mena mRNA abundance since b-catenin can regulate mena transcription (Najafov et al., 2012) . These findings are consistent with the potential existence of regulatory feedback loops that control Mena protein abundance at the transcriptional and translational levels.
Neurons deficient for Ena/VASP proteins fail to respond properly to Netrin and Slit (Dent et al., 2011; Lebrand et al., 2004; McConnell et al., 2016) , two axon guidance cues that require local translation (Campbell et al., 2001; Jung et al., 2012; Jung and Holt, 2011) . Our results raise the possibility that, in addition to its established role in regulating filopodia dynamics in response to Netrin and Slit, Mena could contribute to local translation-dependent responses to these cues. Interestingly, both Mena and HnrnpK have been implicated in synapse formation and plasticity (Folci et al., 2014; Giesemann et al., 2003; Li et al., 2005; Lin et al., 2007; Proepper et al., 2011) , raising the possibility that their synaptic functions involve regulated translation by the Mena-RNP complex. Future work will address how Mena function helps coordinate changes in cytoskeletal dynamics and protein synthesis in response to signals that regulate nervous system development and function.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and reagent requests may be directed to and will be fulfilled by the Lead Contact Frank Gertler (fgertler@mit.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS Animals
All experiments were performed according to the Guide for the Care and Use of Laboratory Animals and were approved by the National Institutes of Health, and the Committee on Animal Care at the Massachusetts Institute of Technology (Cambridge, MA, USA). Female pregnant mice were euthanized with CO 2 and embryos were isolated and further dissected in 10mM HEPES and 1x HBSS (GIBCO/Invitrogen). Mice of the following strains were used: Swiss Webster, mixed background MeNa + /+;VASPÀ/À;EVLÀ/À, Mena+/À;VASPÀ/À;EVLÀ/À, MenaÀ/À;VASPÀ/À;EVLÀ/À (mve), MeNa + /+;VASP+/+;EVL+/+, and MenaÀ/À;VASP+/+;EVL+/+. The embryos were not assessed for their sex.
Primary Neuron Cultures
Cortical neurons from E15.5 mouse brains were plated on poly-D-lysine (PDL, SIGMA) or PDL and Laminin (Southern Biotech) and cultured for 2 days before treatments, unless otherwise indicated. Briefly, cortical tissue was dissected in 10mM HEPES and 1x HBSS, washed and trypsinized in the same buffer for 15min at 37 C. Tissues were then washed in DMEM 1x with 10% FBS to inactivate trypsin, and triturated in the same medium. Following trituration neurons were pelleted at 600 g for 5 min, resuspended in serum-free Neurobasal medium (Invitrogen), supplemented with B27 (GIBCO) and Pen/Strep (GIBCO), and plated on PDL-coated coverslips or petri dishes.
Cell Lines
MEFs and N2A cells were cultured at 37 C, 5% CO 2 , in Dulbecco's modified Eagles's medium (DMEM) supplemented with 10% fetal bovine serum and penicili/streptomycin (Pen/Strep).
METHOD DETAILS Primary Neuron Stimulation with BDNF
Before stimulations with BDNF (50ng/ml; R&D systems) neurons were starved for 4 hr in L15-Leibowitz medium (Invitrogen) and to block translation cells were incubated with 40 mM Anisomycin (Sigma) in L15, for 30min prior to BDNF addition. BDNF was added for 15min. Where needed, neurons were transfected using Amaxa Nucleofector mouse neuron kit (LONZA) according to the manufacturer's instructions. All experiments were repeated at least 3 times to eliminate technical and biological variations. 
Primary Neurons on Transwell Filters/Axotomy
Cortical neurons form E15.5 mouse brains were plated on the top compartment of 6-well hanging inserts with 1um membrane pores (Millipore, PET), coated on both sides of the membrane with PDL. The cells were cultured for 2 days in serum-free Neurobasal medium, supplemented with B27 and Pen/Strep. Prior to stimulation, neurons were starved as described above and the cell bodies were scraped from the top compartment of the filter, leaving the axons at the bottom. BDNF was added to the axons for 15min and after stimulation the bottom compartment was washed with ice cold PBS and lysed for protein or mRNA extraction. 40 mM Anisomycin in L15, for 30min prior to BDNF addition, was used for translational inhibition. All experiments were repeated at least 3 times, to minimize technical and biological variability.
siRNA in Primary Neurons siRNA smartpools against HnrnpK, Pcbp1 and Safb2 were obtained from Dharmacon and introduced in neurons with Amaxa Nucleofection, as per the manufacturer's instructions. A GFP control plasmid provided with the mouse neuron nucleofection kit (LONZA) was co-transfected to visualize cells with the siRNAs. The knockdown efficiency was assessed by IF and microscopy.
Immunofluorescence Coverslips were fixed for 20min at 37 C with 4% PFA in PHEM buffer (120mM Sucrose, 2mM MgCl 2 , 10mM EDTA, 25mM HEPES, 60mM PIPES), rinsed with PBS and then permeabilized with 0.3% Triton X-100 in PBS for 5min at RT. Blocking for 1hr in 10% serum in PBS was followed by incubation with primary antibodies diluted in blocking solution for 1hr at RT. After PBS rinses, secondary antibodies were added to the coverslips, diluted in blocking solution, for 45 min at RT. Phalloidin staining of F-actin was performed for 30 min at RT, followed by PBS rinses and mounting of the coverslips on slides with Fluoromount-G for imaging. Primary antibodies used: Ms-Anti-HnrnpK (1:50, SantaCruz) ms-anti-Mena (1:500) (Lebrand et al., 2004) , Rb-anti-Mena (1:500) and Rb-anti-VASP (1:500) generated in the Gertler laboratory. All secondary antibodies used were from Jackson Laboratories, conjugated to À405, À488, À595, or À647 fluorophores and diluted 1:500.
RNA Fluorescent In Situ Hybridization
RNA FISH was performed using custom Stellaris FISH probes, according to the manufacturer's protocol. Briefly, cells on coverslips were fixed with 4% paraformaldehyde in PBS 1x for 15min at 37 C, and subsequently permeabilized with 0.3% Triton X-100 in PBS for 5min at RT. Coverslips were washed in 10% deionized Formamide, 2x Saline-sodium Citrate (SSC) (wash buffer) for 5min at RT and then hybridized in 10% Formamide, 2x SSC, 10% Dextran sulfate, 0,5 mg/ml Salmon Sperm DNA, 1mg/ml yeast tRNA, 1% BSA, and 125nM of RNA probe, in a dark humidified chamber at 37 C O/N. After hybridization the coverslips were washed in wash buffer at 37 C for 30min in the dark. Wherever IF was performed along with the FISH, the primary antibodies were diluted in the hybridization buffer with the probe and incubated simultaneously and the secondary antibodies were added to the post-hybridization wash (30min at 37 C). After the post-hybridization wash coverslips were incubated with phalloidin in PBS, 30min at RT, rinsed in PBS and mounted on slides with Fluoromount-G (Southern Biotech) for imaging. For the unmasking experiments, neurons were incubated with pepsin for 30sec after fixation, as previously described (Buxbaum et al., 2014) . For the custom probes, the entire mRNA sequence of mouse and human dyrk1a was used on the Stellaris website. All experiments were repeated at least 3 times, and a minimum of 10 neurons per condition per experiment was imaged and used for quantifications.
Immunoprecipitation
Cortical neurons cultured for 3 days in vitro were lysed in lysis buffer (20 mM Tris ph 8.0, 200 mM NaCl, 2 mM MgCl2, 10% glycerol, 1% NP-40) supplemented with Roche complete EDTA-free protease and phosphatase inhibitor tablets) on ice for 20 min. For whole brain lysate, E15.5 mouse brains were homogenized in lysis buffer using a Dounce homogenizer chilled on ice. Collected lysates were cleared by centrifugation for 20 min 14k rpm at 4 C, and incubated overnight at 4 C with antibodies on magnetic protein G beads (incubated in PBS for 4hrs at 4 C. After IP, beads were washed three times with lysis buffer containing 0.4% NP40, and boiled in 2x SDS sample buffer for loading onto an acrylamide gel either for western blotting or for Mass Spectrometry.
HITS-CLIP Modification E15.5 mouse brains were dissected, rinsed and triturated in PBS and UV-irradiated three times at 400 mJ/cm 2 in a Stratalinker (254nm). The tissue suspension was collected by centrifugation and the pellet was lysed in 20 mM Tris ph 8.0, 200 mM NaCl, 2 mM MgCl2, 10% glycerol, 1% NP-40) supplemented with Roche complete EDTA-free protease and phosphatase inhibitor tablets. The lysate was subsequently treated with DNaseI (NEB, M0303L) and RNaseIF (NEB, M0243L) at 37 C and centrifuged for 10 min at 13000rpm. The cleared lysates were then used for a Mena IP. Following the IP, the samples were washed stringently three times with 1M NaCl in lysis/IP buffer and the beads were collected in TRIZOL reagent for RNA extraction, according to the manufacturer's instructions. Purified RNA was subsequently used for the construction of libraries and sequencing on an ILLUMINA Platform (miSeq). The experiment was repeated twice, using 2 biological replicates per sample, per experiment, to eliminate technical and biological variability. Only the mRNAs that had more than 10 reads and 3-fold enrichment between the Mena and control IP samples were considered significant for subsequent analysis.
Oligo dT Capture E15.5 mouse brain lysates were prepared as described above for HITS-CLIP samples. The lysates were then treated with DNase for 5 min at 37 C and centrifuged 20 min at 14000 rpm at 4 C. Half of each lysate was treated with 1mg/ml RNaseA for 15' at 37 C and all of the samples were finally heated at 65 C for 5min and kept on ice. OligodT Dynabeads (Pierce) were added to lysates for 12 min at RT and pelleted on a magnet. Following incubation, the beads were washed three times in 1M NaCl lysis buffer and 2xLaemli Buffer was used for western blot analysis of each sample.
mRNA Pull-Down Assay The sequence of the 3 0 UTR of the dyrk1a and lhx6 mRNA was cloned in a pBS KS vector and linearized. In vitro transcription was carried out on the linearized templates, using the Ampliscribe T7-Flash Biotin-RNA Transcription Kit, according to the manufacturer's instructions (Epicenter), in order to generate biotinylated probes for the 3 0 UTR of dyrk1a mRNA. l-phage DNA and the 3 0 UTR of the lhx6 gene was also used to generate a control, non-specific biotinylated RNA probe, by in vitro transcritpion. Following precipitation and reconstitution in H2O, the biotinylated probes were captured on Streptavidin Dynabeads (My Streptavidin T1 beads, Pierce) for 1hr at RT. E15.5 brains lysed in 20 mM Tris ph 8.0, 200 mM NaCl, 2 mM MgCl2, 10% glycerol, 1% NP-40 supplemented with Roche complete EDTA-free protease and phosphatase inhibitor tablets and RNase Inhibitors (Ambion) were incubated with the beads, O/N at 4 C. The beads were subsequently washed in lysis buffer and processed for western blot analysis.
Western Blot
Protein samples were resolved by SDS-PAGE, transferred to nitrocellulose membranes and immunoblotted. Blocking was performed for 1 hr with 3% BSA in PBS at RT, and then the membranes were incubated with primary antibodies in PBS+0.1% Tween-20, O/N at 4 C. After thorough washes, the membranes were incubated with secondary HRP-conjugated antibodies at 1:5000 dilutions and they were visualized by enhanced chemiluminescence (SuperSignal West Pico Chemluminescent HRP substrate -ThermoFisher). Alternatively, fluorescent LICOR secondary antibodies were used at 1:10000, and the membranes were imaged on Odyssey imagers. Primary antibodies used: Rb-anti-PCBP1 (Abcam) 1:1000; Rb-anti-HnrnpK (Cell Signaling) 1:1000; Ms-anti-SafB2 (Abcam) 1:2000; Ms-anti-Dyrk1a (Abnova) 1:1000; Rb-anti-FMR1 (Cell Signaling) 1:1000; Ms-anti-beta Catenin (BD Biosciences) 1:2000; Rb-anti-HnrnpM (Bethyl Laboratories) 1:1000; Rb-anti-HnrnpA2B1 (Elabscience) 1:1000; Rb-anti-RRBP1 (Bethyl Laboratories) 1:1000; Ms-anti-MBNL1 (E. Wang) 1:1000; Ms-anti-tubulin (DM1A) 1:10000
Mass Spectrometry
We performed two technical replicates of this experiment, each replicate used 2 independent biological replicates for Mena IP from wild-type brains, and 2 replicates for Mena IP from Mena null brains (as a negative control for specificity). During IP for mass spectrometry the anti-Mena antibody (clone A351F7D9) was covalently crosslinked with DMP to protein G magnetic beads. Acrylamide gels were stained with Coomasie Brilliant Blue. After destaining with 40% ethanol/10% acetic acid, proteins were reduced with 20mM dithiothreitol (Sigma) for 1h at 56 C and then alkylated with 60mM iodoacetamide (Sigma) for 1h at 25 C in the dark. Proteins were then digested with 12.5ng/ml modified trypsin (Promega) in 50 mL 100mM ammonium bicarbonate, pH 8.9 at 25 C overnight. Peptides were extracted by incubating the gel pieces with 50% acetonitrile/5% formic acid then 100mM ammonium bicarbonate, repeated twice followed by incubating the gel pieces with 100% acetonitrile then 100mM ammonium bicarbonate, repeated twice. Each fraction was collected, combined, and reduced to near dryness in a vacuum centrifuge. Per manufacturer's instructions, each sample was labeled with a unique iTRAQ 4plex (ABSciex). Following the 1 hr incubation, all samples were combined and concentrated to completion. The combined labeled peptides were desalted using Protea C18 spin tips and resuspended in 0.1% formic acid. Peptides were separated by reverse phase HPLC using an EASY-nLC1000 (Thermo) over a 140 min gradient before nanoelectrospray using a QExactive mass spectrometer (Thermo). Mass spectrometry data were analyzed using Mascot (Matrix Science) and Proteome Discoverer (Thermo).
RT-PCR and Quantitative PCR cDNA synthesis was performed using the Invitrogen Superscript III First Strand Synthesis for RT-PCR kit, with Random Hexamer primers, according to the manufacturer's instructions. Quantitative PCR was performed using the Biorad iQ SYBR Green Supermix on a CFX96 Real Time PCR Detection System, with the following gene-specific primers: 
Imaging
Imaging was performed using a Deltavision microscope (Applied Precision, Issaquah, WA), with a Coolsnap HQ camera (Photometrics); post-acquisition image processing was performed using SoftWoRx v.XX (Applied Precision). Maximum intensity projections of 2-4 optical sections were generated using ImageJ. Only growth cones that were not in contact with other cells or processes and had extended more than 0.3 mm away from the cell body were chosen for imaging. All fluorescence quantitation used original unprocessed image data, with no pixels at zero intensity or saturated. In panels displayed in the figures, for consistent visibility across the intensity range, contrast and brightness were adjusted uniformly within each experimental series.
QUANTIFICATION AND STATISTICAL ANALYSIS
All microscopy experiments were repeated at least 3 times with different biological samples, and at least 10 axons were analyzed per condition, per experiment. Quantified Signal intensities were normalized to cellular area within the region of interest. For colocalization studies, the JaCoP plugin of ImageJ was used to calculate Pearson's Coefficient Corellation, including Coste's Randomization. All biochemical assays were performed at least 3 times with two biological replicates each time per sample, to minimize variability. Statistical significance was assessed either in Excel, or Graphpad Prism6, using Student's t test, non-parametric, or two-way ANOVA, specified in Figure legends for each experiment. All graphs represent mean values ± StDev.
DATA AND SOFTWARE AVAILABILITY
Mena protein interactions identified by IP-Mass Spectrometry are provided in Table S1 . mRNAs associated with Mena, as identified by CLIP-Sequencing, are provided in Table S2 . More information and access to the data are available upon request to the Lead Contact.
